NASDAQ · Drug Manufacturers - Specialty & Generic

Biofrontera Inc (BFRI)

$1.48 0.00%

Add alert

75 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$0.94+57.45%

Company profile

Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Market cap$16.00M

P/E ratioNone

EPS$-1.01

Beta0.798

Dividend yield0.00%

52-week high$1.40

52-week low$0.56

Similar stocks in Drug Manufacturers - Specialty & Generic

HIMS Hims & Hers Health Inc - Class A RSI 58 CGC Canopy Growth Corporation RSI 64 TLRY Tilray Brands Inc - Class 2 RSI 58 LNTH Lantheus Holdings Inc RSI 42 ACB Aurora Cannabis Inc RSI 73 BCRX Biocryst Pharmaceuticals Inc RSI 49 INM InMed Pharmaceuticals Inc RSI 46 ORGO Organogenesis Holdings Inc - Class A RSI 35 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52

Free forever

RSI alerts for BFRI

Get an email the moment Biofrontera Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 14 August 2026 at 8:49 AM EDT